World Health Organization Organisation Mondiale de La Santé February 2009

World Health Organization
Organisation Mondiale de la Sant

Department of
INTRODUCTION
Measurement and Health Information
February 2009
MORTALITY AND BURDEN OF DISEASE ESTIMATES FOR WHO MEMBER STATES IN 2004
This workbook contains estimates of mortality and burden of disease for WHO Member States for the year 2004. These estimates are are generally consistent with the regional-level
results published in the report The global burden of disease: 2004 update (1), with some revisions following a consultation with Member States which took place during late 2008.
These summary tables represent the best estimates of WHO based on evidence available in 2008 rather than the official estimates of Member States. These estimates have been
computed using standard categories and methods to ensure cross-national comparability . Therefore, they are not always the same as official national estimates, nor necessarily
endorsed by specific Member States.
Methods and data sources are summarized in the Annexes of the "Global burden of disease: 2004 update" (1) and the methodology is described in more detail elsewhere (2).
Mortality estimates are based on analysis of latest available national information on levels of mortality and cause distributions as at early 2008. YLD estimates are based on analyses
of incidence, prevalence, duration and severity of conditions for the relevant epidemiological subregion, together with national and subnational level information available to WHO.
The population estimates for WHO Member States for 2004 are those prepared by the UN Population Division in its 2006 revision (3).
WHO has previously released estimates of mortality and burden of disease for WHO Member States for the year 2002. Note that differences between the 2004 estimates and the
previous 2002 estimates should not be interpreted as representing time trends. The 2002 estimates are not generally comparable with those for 2004 due to changes in methods and
data. Some Member States have prepared similar estimates for a recent year that may draw on additional and more specific national data sources (4). Not all such results are
comparable to the estimates included here, due to differences in definitions of cause categories, methods, disability weights and choices for discounting and age weighting.
The work leading to these statistics was undertaken by the WHO Department of Health Statistics and Informatics (IER/HSI) in collaboration with WHO technical programmes and with
scientists worldwide. Documentation and regional summary tables are available on the WHO website (http://www.who.int/evidence/bod), together with software tools and a National
Burden of Disease Manual providing guidelines for conducting national studies (5).
References
1. 1. World Health Organization. The global burden of disease: 2004 update. Geneva, WHO, 2008. Available at www.who.int/evidence/bod
2. Mathers CD, Lopez AD, Murray CJL. The burden of disease and mortality by condition: data, methods and results for 2001. In: Lopez AD, Mathers CD, Ezzati M, Murray CJL,
Jamison DT, eds. Global burden of disease and risk factors. New York, Oxford University Press, 2006: 45-240. Available at http://www.dcp2.org/pubs/GBD.
3. United Nations Population Division. World population prospects - the 2006 revision. 2007. New York, United Nations.
4. WHO website. Links to National Burden of Disease Centres and Studies. http://www.who.int/healthinfo/global_burden_disease/tools_national/en/index.html
5. Mathers CD, Vos T, Lopez AD, Ezzati M. National Burden of Disease Studies: A Practical Guide. Edition 1.1. 2001. Geneva, World Health Organization, Global Program on
Evidence for Health Policy. Available at http://www.who.int/healthinfo/global_burden_disease/tools_national/en/index.html
DISABILITY ADJUSTED LIFE YEARS

The Disability Adjusted Life Year or DALY is a health gap measure that extends the concept of potential years of life lost due to premature death (PYLL) to include equivalent years of
healthy life lost by virtue of being in states of poor health or disability (1). The DALY combines in one measure the time lived with disability and the time lost due to premature
mortality. One DALY can be thought of as one lost year of healthy life and the burden of disease as a measurement of the gap between current health status and an ideal situation
where everyone lives into old age free of disease and disability.
DALYs for a disease or health condition are calculated as the sum of the years of life lost due to premature mortality (YLL) in the population and the years lost due to disability (YLD)
for incident cases of the health condition:
The years of life lost (YLL) basically correspond to the number of deaths multiplied by the standard life expectancy at the age at which death occurs. The basic formula for YLL
(without yet including other social preferences discussed below), is the following for a given cause, age and sex:
YLL = N x L
where:
N = number of deaths
L = standard life expectancy at age of death in years
Because YLL measure the incident stream of lost years of life due to deaths, an incidence perspective is also taken for the calculation of YLD. To estimate YLD for a particular cause
in a particular time period, the number of incident cases in that period is multiplied by the average duration of the disease and a weight factor that reflects the severity of the disease
on a scale from 0 (perfect health) to 1 (dead). The basic formula for YLD is the following (again, without applying social preferences):
YLD = I x DW x L
where:
I = number of incident cases
DW = disability weight
L = average duration of the case until remission or death (years)
Egalitarian principles were explicitly built into the DALY, and the Global Burden of Disease Study used the same values for all regions of the world (2) . It used the same life
expectancy ideal standard for all population subgroups and it excluded all non-health characteristics (such as race, socioeconomic status or occupation) apart from age and sex from
consideration in calculating lost years of healthy life. Most importantly, it used the same disability weight for everyone living a year in a specified health state. Additionally, 3% time
discounting and non-uniform age weights which give less weight to years lived at young and older ages were used in calculating DALYs for the original Global Burden of Disease
study. These value choices have continued to be used for the Global Burden of Disease 2000 study results reported in recent World Health Reports and in these tables.
With non-uniform age weights and 3% discounting, a death in infancy corresponds to 33 DALYs, and deaths at ages 5 to 20 to around 36 DALYs. Thus a disease burden of 3,300
DALYs in a population would be the equivalent of 100 infant deaths or to approximately 5,500 persons aged 50 years living one year with blindness (disability weight 0.6).
References
1. Murray CJL, Salomon JA, Mathers CD, Lopez AD (eds.) (2002). Summary measures of population health: concepts, ethics, measurement and applications. WHO, Geneva.
Available at http://www.who.int/pub/smph/en/index.html
2. Murray CJL, Lopez AD (1996). The Global Burden of Disease. Cambridge: Harvard University Press.

Department of
NOTES FOR TABLES
February 2009
(a) The figures in these table are generally consistent with the Annex Tables published in the WHO report "Global burden of disease: 2004 update" (1). Some revisions have been carried
out for a number of countries following a consultation with Member States which took place during late 2008. Comments or data provided by Member States were discussed with
them and incorporated where appropriate. These summary tables represent the best estimates of WHO based on evidence available in mid-2008 rather than the official estimates
of Member States. These estimates have been computed using standard categories and methods to ensure cross-national comparability . Therefore, they are not always the same as
official national estimates, nor necessarily endorsed by specific Member States. Methods and data sources are summarized in the Annexes of the "Global burden of disease: 2004
update" (1) and the methodology is described in more detail elsewhere (2).
(b) Global Burden of Disease (GBD) cause categories are defined in Annex Table 3 of the "Global burden of disease: 2004 update" (1).
(c) The data sources and methods used for the estimation of total deaths (all causes) for each Member State are summarized into four levels of evidence. Further details of data sources
and methods for each Member State are given in Annex B of reference (1).
Level 1a Complete death registration data available for years 2003 and/or 2004.
Level 1b Complete death registration data available for an earlier time period. All cause mortality projected to 2004.
Level 2a Death registration data available for years 2003 and/or 2004. Completeness for latest year estimated using standard demographic methods for child deaths under age 5
and for deaths at ages 5 and over. Estimated completeness used to adjust death registration data.
Level 2b Death registration data available for available for an earlier time period. Completeness for latest year estimated using standard demographic methods for child deaths
under age 5 and for deaths at ages 5 and over. Estimated completeness used to adjust death registration data and then all cause mortality was projected to 2004.
Level 3a Country information for years 2003 and/or 2004 available on levels of child mortality (between ages 0 and 5) and adult mortality (between ages 15 and 60). WHO
modified logit life table system used with global standard to estimate all cause mortality.
Level 3b Country information available for an earlier time period on levels of child mortality (between ages 0 and 5) and adult mortality (between ages 15 and 60). Child and
adult mortality levels were projected to 2004 and the WHO modified logit life table system used with global standard to estimate all cause mortality.
Level 4a Country information for years 2003 and/or 2004 available on level of child mortality (between ages 0 and 5) only. Levels of adult mortality excluding HIV/AIDS and war
deaths predicted from child mortality. HIV/AIDS and war deaths added separately and WHO modified logit life table system used with global standard to estimate all cause
mortality.
Level 4b Country information prior to 2003 available on level of child mortality (between ages 0 and 5) only. Levels of adult mortality excluding HIV/AIDS and war deaths
predicted from projected 2004 HIV/AIDS-free child mortality. HIV/AIDS and war deaths added separately and WHO modified logit life table system used with global standard to
estimate all cause mortality.
(d) The data sources and methods used for the estimation of deaths by cause for each Member State are summarized into four levels of evidence. Additional information for estimating
country-level deaths due to certain specific causes were obtained from studies, WHO technical Programmes and UNAids for the following conditions: AIDS, tuberculosis, measles,
pertussis, poliomyelitis, tetanus, acute lower respiratory infections, Chagas, maternal conditions, perinatal conditions, cancers, drug use disorders, rheumathoid arthritis and war.
Further details of data sources and methods for each Member State are given in Annex B of reference (1).
Level 1a Complete death registration data with cause of death coded using ICD-9 or ICD-10 available for years 2003 and/or 2004. Less than 10% of deaths coded to ICD codes
for symptoms, signs, and ill-defined conditions, injuries where the intent is not determined; cardiovascular "garbage" codes, and cancer deaths coded to categories for secondary
or unspecified sites.
Level 1b Complete death registration data available . Complete death registration data with cause of death coded using ICD-9 or ICD-10 available for for an earlier time period.
Less than 10% of deaths coded to ICD codes for symptoms, signs, and ill-defined conditions, injuries where the intent is not determined; and cardiovascular and cancer
"garbage" codes.
Level 2a Death registration data available for years 2003 and/or 2004. Adjustments to cause of death distribution required for incomplete registration and/or for use of non-ICD-9
or ICD-10 coding and/or for the more than 10% of deaths coded to ill-defined conditions, and cardiovascular, cancer and injury "garbage" codes.
Level 2b Death registration data available for latest year earlier than 2003. Adjustments to cause of death distribution required for incomplete registration and/or for use of nonICD-9 or ICD-10 coding and/or for the more than 10% of deaths coded to ill-defined conditions, and cardiovascula, cancer and injury "garbage" codes.
Level 3 Country information on causes of death available based on verbal autopsy methods.
Level 4. Country information on causes of death not available for most causes. Cause of death modelling used to estimate broad distribution of causes of death for Groups I, II
and III by age and sex for the country level of all cause mortality and per capita income. Cause of death patterns within the three major cause groups based on death registration
data from other countries in the region. Further country-level information and data on specific causes listed above was also used.
(e) UN estimates of de-facto population (2006 Revision). Estimated death rates by age, sex for underlying causes of death as defined by the ICD classification rules, are applied to the
UN estimates of de-facto resident population for 2004 to give numbers of expected deaths by cause for each Member State.
(g) Does not include liver cancer and cirrhosis deaths or DALYs resulting from chronic hepatitis virus infection.
(h) This cause category includes 'Causes arising in the perinatal period' as defined in the International Classification of Diseases, principally low birthweight, prematurity, birth asphyxia
and birth trauma, and does not include all disability or deaths occurring in the neonatal period (under 28 days after birth). For example, congenital anomalies and injuries may also
occur in the neonatal period but are classified to other cause categories.
(i)
Includes severe neonatal infections and other non-infectious causes arising in the perinatal period.
(j)
Includes macular degeneration and other age-related causes of vision loss not correctable by provision of glasses or contact lenses, together with deaths due to other sense organ
disorders.
(k) Includes myocarditis, pericarditis, endocarditis and cardiomyopathy.

(m Standard DALYs with age-weighting and time discounting as reported in World Health Report 2004 (see second box on Introduction sheet).
)
(n) The data sources and methods used for the estimation of the YLL (premature mortality) component of DALYs are summarized as described in notes (c) and (d). YLD estimates by
cause for Member States are based on the GBD analyses of incidence, prevalence, duration and severity of conditions for the relevant epidemiological subregion, together with
country-level and subregional mortality differentials, and other national and subnational level information available to WHO. Two levels of evidence are distinguished as listed below.
Further details of data sources and methods for each Member State are given in Annex B of reference (1).
Level 3 Country data on causes of death (Levels 1 to 3) used to adjust regional YLD distributions for causes with significant case fatality. Partial country-specific information on
incidence or prevalence of non-fatal causes available.
Level 4. Level 4 information on causes of death and regional estimates of YLD used for most causes. Partial country-specific information on incidence or prevalence of some
non-fatal causes available.
(p) Cause-specific death rates were age-standardized to the WHO global standard population (see Discussion Paper 31, http://www.who.int/healthinfo/paper31.pdf). Age-standardized
death rates are calculated by applying age-specific death rates for the Member State to a global standard population. Comparison of cause-specific mortality risks across countries is
facilitated by the use of age-standardized death rates to adjust for differences in population age distributions.
References
1. World Health Organization. The global burden of disease: 2004 update. Geneva, WHO, 2008. Available at www.who.int/evidence/bod
2. Mathers CD, Lopez AD, Murray CJL. The burden of disease and mortality by condition: data, methods and results for 2001. In: Lopez AD, Mathers CD, Ezzati M, Murray CJL,
Jamison DT, eds. Global burden of disease and risk factors. New York, Oxford University Press, 2006: 45-240. Available at http://www.dcp2.org/pubs/GBD.
3. Mathers CD, Salomon JA, Ezzati M, Begg S, Lopez AD. Sensitivity and uncertainty analyses for burden of disease and risk factor estimates. In: Lopez AD, Mathers CD, Ezzati M,
Murray CJL, Jamison DT, eds. Global burden of disease and risk factors. New York, Oxford University Press, 2006: 399-426.Available at http://www.dcp2.org/pubs/GBD.

Department of
COLOUR CODES FOR LEVELS OF EVIDENCE
February 2009
Columns containing estimates of deaths or DALYs for WHO Member States in 2004 are colour-coded in the following sheets to summarize the levels of evidence and uncertainty. Four levels of
evidence for all cause mortality, cause-specific mortality, and DALYs are defined in the Notes sheet. Three colour codes are used to denote the following levels:
Total
mortality
Causes of
death
Level 1
or Level 2
Level 1
or Level 2
YLD
Level 3
Death registration data, complete or incomplete, containing useable information on causes of death is available for the country, and
used to adjust regional YLD distributions for causes with significant case fatality. Partial country-specific information on incidence or
prevalence of non-fatal causes available.
Total mortality or causes of death

have level 3 evidence, neither is
level 4.
Other forms of information on child and adult mortality or causes of death (eg. verbal autopsy) available. Country-specific information on
mortality for specific causes available.Partial country-specific information on incidence or prevalence of non-fatal causes available.
Level 4 OR Level 4
Country information on level of adult mortality not available and it was predicted from child mortality level OR cause of death information
for most causes not available, and cause pattern predicted using cause-of-death models. Partial country-specific information on
incidence or prevalence of non-fatal causes available.
Level 4
Note that levels of evidence will vary for specific causes within a country, and the above colour coded scheme does not attempt to provide that level of detail for most causes. For
tuberculosis, HIV/AIDS, vaccine-preventable diseases, some tropical diseases and maternal mortality, specific colour codes have been used to provide an indication of when country-level
data were used for those causes, for countries where the general level of evidence is level 4 (pink). Information on the sources of mortality and epidemiological data for each country is
given in Annex B of the Global burden of disease:2004 update report (1).
Estimated 95% uncertainty ranges for the expected number of total deathsfor 2004 are given for each country in the Excel file for all ages, both sexes. These provide some indication of the
level of uncertainty for estimates in that country. Cause-specific estimates will generally have even greater relative uncertainty ranges, as will DALY estimates, with the possible exception of
some causes such as HIV/AIDS where separate country-specific analyses have been used. For more details on data source, methods and uncertainty refer to the references below.
References
1. World Health Organization. The global burden of disease: 2004 update. Geneva, WHO, 2008. Available at www.who.int/evidence/bod
GBD code
GBD cause (b)

WHO Country code
FEMALES
Population ('000) (e)
W001
W002
W003
W004
W005
W006
W007
W009
W010
W011
W012
W013
W014
W015
W016
W017
W018
W019
W020
W021
W022
W023
W024
W025
W026
W027
W028
W029
W030
W031
W032
W033
W034
W035
W038
W039
W040
W041
W042
W049
W050
W051
W052
W053
W054
W055
W056
W057
W059
W060
W061
W062
W063
W064
W065
W066
W067
W068
W069
Albania
Algeria
Andorra
Angola
Antigua and
Barbuda
Argentina
Armenia
Australia
3010
4005
1010
4008
1020
2010
2020
4007
5020
Level 4b
Level 2b
Level 3b
Level 3b
Level 4b
Level 3b
Level 1b
Level 2b
Level 1b
Level 4
Level 2b
Level 4
Level 4
Level 4
Level 2b
Level 2a
Level 2a
Level 2b
Data sources - level of evidence

All cause mortality (c)
Cause-specific mortality (d)
W000
Afghanistan
All Causes
I. Communicable, maternal, perinatal and

nutritional conditions
A. Infectious and parasitic diseases
1. Tuberculosis
2. STDs excluding HIV
a. Syphilis
b. Chlamydia
c. Gonorrhoea
3. HIV/AIDS
4. Diarrhoeal diseases
5. Childhood-cluster diseases
a. Pertussis
b. Poliomyelitis
c. Diphtheria
d. Measles
e. Tetanus
6. Meningitis
7. Hepatitis B (g)
Hepatitis C (g)
8. Malaria
9. Tropical-cluster diseases
a. Trypanosomiasis
b. Chagas disease
c. Schistosomiasis
d. Leishmaniasis
e. lymphatic filariasis
f. Onchocerciasis
10. Leprosy
11. Dengue
12. Japanese encephalitis
13. Trachoma
14. Intestinal nematode infections
a. Ascariasis
b. Trichuriasis
c. Hookworm disease
B. Respiratory infections
1. Lower respiratory infections
2. Upper respiratory infections
3. Otitis media
C. Maternal conditions
D. Perinatal conditions (h)
1. Prematurity and low birth weight
2. Birth asphyxia and birth trauma
3. Neonatal infections and other conditions (i)
E. Nutritional deficiencies
1. Protein-energy malnutrition
2. Iodine deficiency
3. Vitamin A deficiency
4. Iron-deficiency anaemia
II. Noncommunicable diseases

A. Malignant neoplasms
1. Mouth and oropharynx cancers
2. Oesophagus cancer
3. Stomach cancer
4. Colon and rectum cancers
5. Liver cancer
6. Pancreas cancer
7. Trachea, bronchus, lung cancers
8. Melanoma and other skin cancers
9. Breast cancer
03/23/2016 +
11,605
1,573
16,030
37
7,930
41
19,605
1,613
10,098
245.5
11.2
84.9
0.3
171.8
0.3
133.6
20.4
64.4
182.6
0.7
24.6
0.0
130.9
0.0
19.0
0.7
3.4
68.7
4.8
0.6
0.4
0.1
0.0
0.0
35.9
4.9
3.1
0.0
0.0
0.1
1.6
3.0
1.0
0.5
0.1
0.3
0.3
0.0
0.0
0.0
0.0
0.0
59.5
58.7
0.8
0.0
20.9
25.7
6.0
6.7
0.2
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.3
0.3
0.0
0.0
0.2
0.1
0.0
7.9
0.2
0.2
0.1
0.0
0.0
0.1
4.5
0.3
0.3
0.0
0.0
0.1
0.0
0.8
0.0
0.0
0.0
0.1
0.0
0.1
0.0
0.0
0.0
0.0
0.0
8.1
8.0
0.1
0.0
1.2
6.7
2.9
1.7
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
61.3
1.3
0.4
0.3
0.0
0.0
5.2
26.4
3.1
2.2
0.0
0.0
0.4
0.4
4.1
0.3
0.1
10.2
1.4
0.9
0.4
0.1
0.0
0.0
0.0
0.0
0.0
37.1
36.5
0.5
0.1
10.9
15.2
4.7
4.4
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
7.0
0.3
0.0
0.0
0.4
0.2
0.0
0.0
0.0
0.0
0.2
0.0
0.1
0.2
0.2
0.0
0.0
0.0
8.1
8.1
0.0
0.3
2.5
1.4
0.4
0.2
0.1
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.2
0.2
0.0
0.0
0.2
0.1
0.1
0.9
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
2.1
2.1
0.0
0.0
0.0
0.3
0.0
0.0
13.0
7.8
5.4
0.1
0.0
1.1
0.1
0.0
0.0
0.0
2.1
0.7
0.2
0.0
0.0
0.5
0.0
0.0
0.0
0.0
6.1
6.4
5.6
0.0
0.3
0.3
0.0
0.0
0.0
0.0
0.8
1.1
0.7
0.0
0.3
0.1
0.0
0.0
0.2
0.2
0.1
0.1
55.2
8.1
0.4
0.9
0.8
0.4
0.2
0.1
0.3
0.1
1.7
10.0
1.8
0.0
0.0
0.1
0.2
0.0
0.1
0.2
0.0
0.4
53.9
8.7
0.3
0.1
0.5
0.7
0.1
0.3
0.3
0.1
1.8
0.3
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
34.4
5.8
0.4
0.1
0.7
0.2
0.3
0.0
0.2
0.2
1.1
0.3
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
110.0
27.1
0.2
0.7
1.2
3.3
0.8
1.9
2.2
0.3
6.2
19.4
2.8
0.0
0.0
0.3
0.2
0.1
0.1
0.2
0.0
0.8
58.5
16.9
0.2
0.4
0.6
2.3
0.3
1.0
2.6
0.6
3.1
W070
W071
W072
W073
W074
W075
W076
W078
W079
W080
W081
W082
W083
W084
W085
W086
W087
W088
W089
W090
W091
W092
W093
W094
W095
W098
W099
W100
W101
W102
W103
W104
W105
W106
W107
W108
W109
W111
W112
W113
W115
W116
W117
W118
W120
W121
W122
W124
W125
W126
W127
W131
W143
W144
W145
W146
W148
W149
W150
W151
W152
W153
W154
W155
W156
W157
W158
W159
B.
C.
D.
E.
F.
G.
H.
I.
J.
K.
L.
M.
N.
10. Cervix uteri cancer

11. Corpus uteri cancer
12. Ovary cancer
13. Prostate cancer
14. Bladder cancer
15. Lymphomas, multiple myeloma
16. Leukaemia
Other neoplasms
Diabetes mellitus
Endocrine disorders
Neuropsychiatric conditions
1. Unipolar depressive disorders
2. Bipolar disorder
3. Schizophrenia
4. Epilepsy
5. Alcohol use disorders
6. Alzheimer and other dementias
7. Parkinson disease
8. Multiple sclerosis
9. Drug use disorders
10. Post-traumatic stress disorder
11. Obsessive-compulsive disorder
12. Panic disorder
13. Insomnia (primary)
14. Migraine
Sense organ diseases
1. Glaucoma
2. Cataracts
3. Refractive errors
4. Hearing loss, adult onset
5. Macular degeneration and other (j)
Cardiovascular diseases
1. Rheumatic heart disease
2. Hypertensive heart disease
3. Ischaemic heart disease
4. Cerebrovascular disease
5. Inflammatory heart diseases (k)
Respiratory diseases
1. Chronic obstructive pulmonary disease
2. Asthma
Digestive diseases
1. Peptic ulcer disease
2. Cirrhosis of the liver
3. Appendicitis
Genitourinary diseases
1. Nephritis and nephrosis
2. Benign prostatic hypertrophy
Skin diseases
Musculoskeletal diseases
1. Rheumatoid arthritis
2. Osteoarthritis
Congenital anomalies
Oral conditions
1. Dental caries
2. Periodontal disease
3. Edentulism
III.Injuries
A. Unintentional injuries
1. Road traffic accidents
2. Poisonings
3. Falls
4. Fires
5. Drownings
6. Other unintentional injuries
B. Intentional injuries
1. Self-inflicted injuries
2. Violence
3. War
0.3
0.1
0.5
0.1
0.5
0.8
0.8
1.3
1.5
2.1
0.0
0.0
0.3
0.0
0.1
0.0
0.0
0.6
0.0
0.0
26.5
1.0
2.8
10.9
5.0
0.9
3.1
1.2
0.5
5.5
0.1
2.2
0.0
2.8
2.5
0.1
0.1
0.0
0.0
3.4
0.0
-
0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.1
0.4
0.0
0.0
0.0
0.1
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
6.8
0.0
0.4
2.0
2.7
0.1
0.3
0.1
0.1
0.2
0.0
0.0
0.2
0.2
0.0
0.0
0.0
0.0
0.1
-
1.1
0.1
0.4
0.2
0.7
0.3
0.3
3.9
1.2
1.8
0.0
0.0
0.0
0.5
0.0
0.6
0.1
0.0
0.0
0.0
0.0
26.3
0.2
2.2
6.2
10.1
1.0
4.7
1.6
1.0
3.5
0.5
0.3
0.0
1.6
1.4
0.4
0.5
0.1
0.1
0.9
0.0
0.0
0.0
-
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
-
1.1
0.1
0.3
0.1
0.4
0.1
0.3
2.3
0.9
1.5
0.0
0.0
0.0
0.6
0.0
0.2
0.0
0.0
0.0
0.0
0.0
14.4
0.2
1.0
3.2
5.6
0.7
3.5
0.9
0.7
2.8
0.3
0.2
0.0
1.2
1.1
0.2
0.2
0.0
0.0
1.2
0.0
0.0
0.0
-
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
-
1.6
1.2
1.1
0.4
1.2
0.9
1.4
4.8
1.5
3.5
0.0
0.0
0.0
0.1
0.1
2.0
0.3
0.1
0.1
0.0
0.0
46.5
0.1
2.6
13.2
12.0
1.4
13.0
1.4
0.4
5.0
0.2
0.6
0.0
4.2
3.4
0.9
0.5
0.2
0.0
1.4
0.0
-
0.2
0.1
0.2
0.1
0.1
0.1
0.0
1.7
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
12.9
0.1
0.4
7.6
4.2
0.1
0.7
0.6
0.1
0.6
0.1
0.4
0.0
0.3
0.1
0.0
0.1
0.0
0.0
0.1
-
0.3
0.3
0.8
0.3
1.2
0.7
0.4
1.6
0.8
4.4
0.0
0.0
0.0
0.1
0.0
3.0
0.4
0.1
0.0
0.0
0.0
0.0
25.6
0.2
0.9
12.2
7.4
0.4
3.6
2.3
0.2
2.2
0.2
0.3
0.0
1.7
1.2
0.2
0.7
0.1
0.1
0.3
0.0
0.0
-
7.6
6.2
0.4
0.3
6.3
4.6
0.0
0.0
6.5
5.0
0.0
0.0
4.7
3.6
0.4
0.3
2.5
1.9
2.4
0.3
0.4
0.8
0.7
1.6
1.4
1.0
0.1
0.3
0.1
0.0
0.0
0.0
0.0
0.1
0.1
0.1
0.0
-
1.8
0.6
0.4
0.6
0.3
0.9
1.7
0.6
0.9
0.2
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
-
2.1
0.5
0.2
0.7
0.6
0.9
1.5
0.5
1.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
-
0.8
0.1
0.1
0.2
0.1
2.3
1.1
0.7
0.4
-
0.1
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
-
0.4
0.2
0.3
0.0
0.0
0.9
0.5
0.5
0.1
-
Refer to Notes sheet for notes on this table.
03/23/2016 +

Incidence, prevalence, severity, duration (n)
W000
W001
W002
W003
W004
W005
W006
W007
W009
W010
W011
W012
W013
W014
W015
W016
W017
W018
W019
W020
W021
W022
W023
W024
W025
W026
W027
W028
W029
W030
W031
W032
W033
W034
W035
W038
W039
W040
W041
W042
W049
W050
W051
W052
W053
W054
W055
W056
W057
W059
W060
W061
W062
W063
W064
W065
W066
W067
W068
W069
W070
W071
W072
W073
W074
W075
W076
W078
W079
W080
W081
W082
W083
W084
W085
W086
W087
W088
W089
W090
W091
W092
W093
W094
W095
W098
W099
W100
W101
W102
W103
W104
W105
W106
W107
W108
W109
W111
W112
W113
All Causes

1. Tuberculosis
a. Syphilis
b. Chlamydia
c. Gonorrhoea
3. HIV/AIDS
a. Pertussis
b. Poliomyelitis
c. Diphtheria
d. Measles
e. Tetanus
6. Meningitis
7. Hepatitis B (g)
Hepatitis C (g)
8. Malaria
a. Trypanosomiasis
b. Chagas disease
c. Schistosomiasis
d. Leishmaniasis
f. Onchocerciasis
10. Leprosy
11. Dengue
13. Trachoma
a. Ascariasis
b. Trichuriasis
c. Hookworm disease
3. Otitis media

3. Stomach cancer
5. Liver cancer
6. Pancreas cancer
9. Breast cancer
12. Ovary cancer
13. Prostate cancer
14. Bladder cancer
16. Leukaemia
B. Other neoplasms
C. Diabetes mellitus
D. Endocrine disorders
E. Neuropsychiatric conditions
2. Bipolar disorder
3. Schizophrenia
4. Epilepsy
12. Panic disorder
14. Migraine
F. Sense organ diseases
1. Glaucoma
2. Cataracts
G. Cardiovascular diseases
H. Respiratory diseases
2. Asthma
03/23/2016 +
Level 4b
Level 2b
Level 3b
Level 3b
Level 4b
Level 3b
Level 1b
Level 2b
Level 1b
Level 4
Level 4
Level 2b
Level 3
Level 4
Level 4
Level 4
Level 4
Level 4
Level 4
Level 2b
Level 3
Level 2a
Level 3
Level 2a
Level 3
Level 2b
Level 3
11,605
1,573
16,030
37
7,930
41
19,605
1,613
10,098
9,349
229
2,636
6,087
2,764
272
1,060
7,203
36
930
4,728
422
33
50
2,345
127
52
15
21
15
0
1,206
170
110
0
2
6
53
103
27
13
5
10
10
0
1
0
11
7
3
3
2
2,140
2,109
27
5
1,363
1,005
261
294
7
0
1
0
1
0
0
3
0
0
0
0
0
0
0
0
0
0
0
0
2,126
40
44
12
16
15
163
866
108
77
0
2
16
14
139
8
3
395
70
30
16
4
19
1
1
0
25
19
2
4
1,201
1,180
16
6
515
601
174
212
0
0
0
0
0
0
0
0
0
0
4
4
0
0
8
6
3
2
310
7
75
6
38
30
5
97
19
16
0
0
2
0
27
0
0
0
3
1
2
0
0
0
9
37
27
3
7
105
100
2
4
176
265
103
85
148
6
29
2
17
9
16
23
1
1
0
0
0
0
6
0
1
0
16
15
1
0
3
1
2
1
52
47
1
4
73
110
49
33
11
2
2
0
2
0
0
3
0
0
0
0
0
1
0
0
0
0
0
0
3
3
0
0
6
11
4
5
15
0
3
0
3
0
0
3
0
0
0
0
1
0
0
0
0
0
0
8
6
0
1
3
19
5
5
450
350
235
8
0
68
2
10
3
4
3
76
75
25
5
0
44
29
39
16
0
0
22
2
3
0
0
0
2
8
5
0
1,749
169
7
14
14
7
4
2
6
2
33
7
2
10
1
13
26
15
21
35
417
173
26
31
20
0
6
2
3
18
9
8
18
7
27
146
5
27
54
44
15
444
33
35
137
92
21
96
16
35
179
23
0
0
1
2
0
1
2
0
6
3
1
1
0
1
1
1
3
4
54
22
3
4
2
1
3
1
1
1
1
2
2
1
3
13
1
1
4
5
2
51
0
2
15
17
1
5
2
2
1,472
106
4
1
5
7
1
2
3
1
24
13
1
5
1
10
7
5
47
44
425
146
46
47
23
1
12
1
4
6
13
23
28
7
15
265
32
109
38
60
26
246
5
19
50
92
15
78
16
26
2,203
271
2
4
10
25
6
14
21
3
64
23
19
13
2
12
13
13
108
39
751
278
42
50
27
41
61
3
5
31
11
24
27
16
42
213
19
47
57
57
33
278
1
13
82
91
12
164
25
45
230
33
0
0
3
2
1
1
2
0
10
3
2
2
1
2
2
0
16
4
52
24
4
4
1
1
4
0
0
0
1
2
2
1
2
19
1
2
4
9
3
69
2
2
37
24
1
8
5
2
0
0
1
0
0
0
0
0
0
-
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
215
285
234
4
12
30
1,063
93
5
1
9
2
3
0
3
3
16
18
2
5
1
9
2
6
31
52
224
60
19
20
23
2
5
1
2
2
5
12
12
3
7
95
11
38
15
22
9
224
7
13
38
80
19
97
14
28
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
5
953
159
2
2
4
19
2
6
20
5
43
4
5
8
2
8
6
2
22
25
304
105
14
12
4
26
56
7
3
8
8
5
11
9
17
69
3
1
10
39
16
113
2
4
49
34
4
125
90
26
W115
W116
W117
W118
W120
W121
W122
W124
W125
W126
W127
W131
W143
W144
W145
W146
W148
W149
W150
W151
W152
W153
W154
W155
W156
W157
W158
W159
I.
J.
K.
L.
M.
N.
Digestive diseases
3. Appendicitis
Skin diseases
2. Osteoarthritis
Oral conditions
1. Dental caries
3. Edentulism
III.Injuries
2. Poisonings
3. Falls
4. Fires
5. Drownings
2. Violence
3. War
108
3
42
1
58
45
7
41
10
18
179
14
10
1
4
4
0
0
12
3
7
4
2
1
0
1
72
8
5
1
25
19
18
70
10
45
57
14
8
1
4
397
339
15
10
99
11
43
45
25
115
58
44
6
6
2
1
2
0
1
5
4
3
1
0
0
3
2
-
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
87
8
4
1
30
23
10
29
4
17
78
7
5
0
1
234
173
0
0
296
236
0
0
139
101
9
8
57
43
61
12
11
17
9
64
60
13
35
13
0
0
0
0
0
0
0
0
0
0
88
12
14
28
18
76
60
13
38
8
0
0
0
0
0
0
0
0
0
0
33
2
11
4
4
48
37
18
19
1
2
0
1
0
0
4
1
0
0
0
12
5
11
1
1
13
14
11
3
-
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
67
1
7
0
28
22
18
123
37
57
81
49
28
1
20
1
10
2
5
4
3
2
0
1
38
1
4
0
9
4
1
61
12
34
16
8
5
0
3
7
1
3
0
3
1
-
03/23/2016 +

W000
W001
W002
W003
W004
W005
W006
W007
W009
W010
W011
W012
W013
W014
W015
W016
W017
W018
W019
W020
W021
W022
W023
W024
W025
W026
W027
W028
W029
W030
W031
W032
W033
W034
W035
W038
W039
W040
W041
W042
W049
W050
W051
W052
W053
W054
W055
W056
W057
W059
W060
W061
W062
W063
W064
W065
W066
W067
W068
W069
W070
W071
W072
W073
W074
W075
W076
W078
W079
W080
W081
W082
W083
W084
W085
W086
W087
W088
W089
W090
W091
W092
W093
W094
W095
W098
W099
W100
W101
W102
W103
W104
W105
W106
W107
W108
W109
W111
W112
W113
W115
Level 4b
Level 2b
Level 3b
Level 3b
Level 4b
Level 3b
Level 1b
Level 2b
Level 1b
Level 4
Level 2b
Level 4
Level 4
Level 4
Level 2b
Level 2a
Level 2a
Level 2b
11,605
1,573
16,030
37
7,930
41
19,605
1,613
10,098
All Causes
2,115.5
712.2
529.7
791.9
2,166.0
713.5
681.7
1,266.9
638.0
1,573.8
46.5
153.7
37.7
1,650.5
91.7
97.0
42.4
34.0
592.3
41.4
5.4
3.5
0.9
0.3
0.0
309.2
42.0
26.4
0.0
0.4
1.3
13.9
25.9
8.3
4.0
0.5
2.4
2.4
0.0
0.0
0.0
0.1
0.1
513.1
506.2
6.7
0.2
180.1
221.5
52.0
57.7
12.2
1.4
0.0
0.0
4.6
0.0
0.0
0.0
1.7
0.0
0.0
0.2
0.1
0.1
20.1
18.9
1.2
3.1
9.8
4.5
2.0
49.3
1.3
1.5
0.5
0.0
0.0
0.7
27.9
2.1
1.6
0.0
0.0
0.4
0.1
5.2
0.1
0.1
0.0
0.6
0.1
0.4
0.0
0.0
0.0
0.0
0.0
50.6
50.1
0.4
0.1
7.4
41.9
17.9
10.7
12.1
0.9
0.1
0.0
1.4
1.2
0.0
0.0
0.7
0.2
1.2
0.0
0.0
20.2
20.0
0.2
0.1
3.2
0.5
1.2
772.6
16.2
5.3
3.8
0.1
0.1
66.0
332.4
38.7
27.1
0.1
0.6
5.6
5.3
52.1
3.2
1.4
129.2
18.2
11.6
5.1
1.5
0.0
0.2
0.0
0.1
0.1
468.3
460.5
6.3
1.5
138.0
191.3
58.8
55.8
48.2
8.1
1.8
3.9
24.8
24.8
10.9
8.6
1.6
35.6
1.4
0.2
0.1
2.2
1.0
0.1
0.1
0.0
0.0
1.0
0.1
0.4
1.0
1.0
0.0
0.0
0.0
41.2
41.2
0.0
1.8
12.7
6.9
1.9
13.6
4.8
0.2
0.1
0.0
0.9
4.4
0.1
0.0
0.0
0.1
0.0
1.8
0.1
0.0
0.0
10.7
10.1
0.6
1.6
15.0
7.0
4.2
8.6
0.1
0.1
0.0
0.1
0.2
0.2
0.2
0.3
0.0
0.2
20.8
20.7
0.1
0.0
0.1
2.9
0.4
0.4
111.7
66.9
46.8
0.9
0.1
9.3
3.3
1.3
0.7
0.5
13.4
4.4
1.3
0.0
0.0
2.9
1.4
2.2
0.4
1.3
76.8
80.2
70.0
0.2
4.2
3.5
0.8
7.8
1.1
6.7
3.9
5.7
3.8
0.0
1.6
3.8
1.4
1.4
2.2
1.6
0.5
0.9
476.0
70.1
3.3
7.4
7.0
3.1
1.7
0.8
3.0
1.0
14.7
2.9
0.9
4.0
0.9
4.2
7.0
6.8
11.1
12.9
18.0
0.1
0.1
2.7
0.0
0.6
0.1
0.2
5.4
0.4
0.4
228.0
8.8
23.7
94.0
42.8
7.9
27.1
10.3
4.5
47.0
638.3
111.3
2.0
0.9
6.4
12.6
2.8
4.3
11.5
2.2
28.5
9.4
3.3
5.7
2.4
3.9
3.6
6.7
8.6
3.6
24.6
0.1
0.2
0.8
3.5
0.1
3.3
1.4
2.8
0.3
1.1
0.3
0.8
433.0
0.9
27.4
130.1
170.9
6.0
18.7
8.6
6.1
12.2
336.5
54.1
1.9
0.5
3.2
4.1
0.8
1.6
2.1
0.5
11.4
6.8
0.7
2.4
1.0
4.1
2.1
1.9
24.4
7.8
11.3
0.1
0.0
0.2
3.1
0.2
3.6
0.5
0.1
0.1
0.1
0.1
164.4
1.2
13.5
38.4
63.1
6.3
29.6
10.1
6.4
21.7
730.7
170.1
1.8
1.1
11.5
27.6
7.2
9.9
9.0
3.0
33.1
2.9
6.3
7.7
3.7
12.7
6.9
6.8
23.1
6.9
86.6
0.1
0.1
0.3
0.7
0.2
73.2
5.2
0.5
0.0
0.0
304.2
5.4
17.8
87.6
91.0
8.7
56.6
17.9
3.1
39.7
433.3
73.2
5.2
0.8
8.8
2.3
3.5
0.2
2.3
2.3
14.5
14.4
1.4
3.2
0.9
5.3
1.1
3.5
29.4
11.9
19.0
0.1
0.0
0.4
7.2
0.3
2.5
0.4
0.1
0.1
0.2
0.2
181.7
2.8
13.1
40.2
70.1
9.4
43.6
11.6
8.8
34.7
608.7
126.6
1.6
3.8
4.3
6.7
6.2
11.0
5.0
2.6
36.8
13.1
7.8
2.4
1.6
7.8
1.8
5.3
94.7
23.4
9.1
6.0
1.2
291.5
2.4
91.2
68.1
77.6
3.8
14.9
2.5
1.6
21.7
560.9
138.3
1.3
3.5
6.3
16.9
4.1
9.6
11.3
1.7
31.5
8.0
6.3
5.7
1.9
6.1
4.8
7.0
24.7
7.8
17.8
0.1
0.0
0.0
0.5
0.3
10.1
1.6
0.4
0.3
0.0
0.0
237.3
0.5
13.1
67.4
61.2
7.3
66.4
7.0
2.2
25.5
1,201.8
174.8
1.9
1.9
16.8
10.0
5.0
4.4
13.2
2.5
46.8
11.5
7.0
10.0
4.6
9.0
6.7
0.7
105.1
3.9
6.7
0.0
0.0
0.2
1.3
0.5
1.5
0.7
0.3
0.1
0.0
802.2
8.3
24.0
468.6
257.7
6.0
46.3
36.0
6.8
37.8
579.8
167.7
2.4
4.2
5.5
23.1
3.0
9.6
25.4
5.8
30.6
2.9
3.1
8.0
3.2
12.0
6.7
4.0
16.1
7.9
44.0
0.3
0.1
0.2
1.4
0.5
29.9
3.8
0.7
0.4
0.0
0.0
0.0
253.5
1.9
8.8
120.4
73.6
3.8
36.1
22.6
2.0
22.1

1. Tuberculosis
a. Syphilis
b. Chlamydia
c. Gonorrhoea
3. HIV/AIDS
a. Pertussis
b. Poliomyelitis
c. Diphtheria
d. Measles
e. Tetanus
6. Meningitis
7. Hepatitis B (g)
Hepatitis C (g)
8. Malaria
a. Trypanosomiasis
b. Chagas disease
c. Schistosomiasis
d. Leishmaniasis
f. Onchocerciasis
10. Leprosy
11. Dengue
13. Trachoma
a. Ascariasis
b. Trichuriasis
c. Hookworm disease
3. Otitis media

3. Stomach cancer
5. Liver cancer
6. Pancreas cancer
9. Breast cancer
12. Ovary cancer
13. Prostate cancer
14. Bladder cancer
16. Leukaemia
B. Other neoplasms
2. Bipolar disorder
3. Schizophrenia
4. Epilepsy
12. Panic disorder
14. Migraine
1. Glaucoma
2. Cataracts
2. Asthma
I. Digestive diseases
03/23/2016 +
W116
W117
W118
W120
W121
W122
W124
W125
W126
W127
W131
W143
W144
W145
W146
W148
W149
W150
W151
W152
W153
W154
W155
W156
W157
W158
W159
J.
K.
L.
M.
N.

3. Appendicitis
Skin diseases
2. Osteoarthritis
Oral conditions
1. Dental caries
3. Edentulism
III.Injuries
2. Poisonings
3. Falls
4. Fires
5. Drownings
2. Violence
3. War
1.2
19.3
0.1
23.8
21.5
0.6
1.0
0.2
0.0
29.1
0.0
-
0.4
0.0
10.5
9.6
0.3
2.5
1.0
0.0
5.3
-
2.8
1.8
0.1
10.3
9.0
2.5
3.0
0.4
0.3
5.5
0.2
0.0
0.0
-
1.2
9.5
0.1
18.9
15.1
2.3
12.2
0.9
0.4
3.2
0.1
-
3.6
2.8
0.3
15.0
13.3
3.0
2.8
0.3
0.2
14.8
0.3
0.0
0.1
-
1.3
4.2
12.7
11.6
3.8
2.6
2.3
-
0.8
2.8
0.1
21.6
17.2
4.6
2.6
0.8
0.1
7.2
0.0
-
4.8
23.0
0.2
15.7
7.7
0.3
4.0
2.1
0.0
4.4
-
2.0
2.6
0.1
16.4
11.5
1.9
7.0
1.4
0.6
2.8
0.1
0.0
-
65.6
53.4
27.5
18.8
39.5
28.6
23.5
19.2
82.3
63.4
13.1
10.5
23.8
18.3
22.6
19.8
24.3
18.9
21.1
2.7
3.4
6.7
6.2
13.4
12.2
8.8
4.9
2.6
1.2
0.4
1.8
7.9
8.6
6.2
11.3
3.9
2.3
3.7
1.8
5.6
10.9
3.7
7.1
1.0
3.4
0.3
0.3
7.2
4.3
3.8
26.9
5.7
2.4
9.4
7.0
11.9
18.9
5.8
1.3
1.3
1.1
1.7
5.0
2.6
-
4.2
0.4
0.5
0.8
0.6
11.8
5.5
3.7
5.2
2.3
1.4
1.6
0.3
9.0
2.8
1.9
4.2
2.1
3.3
0.3
0.4
8.6
5.3
4.6
0.9
2.2
2.1
-
5.8
1.5
0.4
-
12.3
0.8
2.6
-
1.8
-
1.0
-
0.8
-
03/23/2016 +

W000
W001
W002
W003
W004
W005
W006
W007
W009
W010
W011
W012
W013
W014
W015
W016
W017
W018
W019
W020
W021
W022
W023
W024
W025
W026
W027
W028
W029
W030
W031
W032
W033
W034
W035
W038
W039
W040
W041
W042
W049
W050
W051
W052
W053
W054
W055
W056
W057
W059
W060
W061
W062
W063
W064
W065
W066
W067
W068
W069
W070
W071
W072
W073
W074
W075
W076
W078
W079
W080
W081
W082
W083
W084
W085
W086
W087
W088
W089
W090
W091
W092
W093
W094
W095
W098
W099
W100
W101
W102
W103
W104
W105
W106
W107
W108
W109
W111
W112
W113
Level 4b
Level 2b
Level 3b
Level 3b
Level 4b
Level 3b
Level 1b
Level 2b
Level 1b
Level 4
Level 4
Level 2b
Level 3
Level 4
Level 4
Level 4
Level 4
Level 4
Level 4
Level 2b
Level 3
Level 2a
Level 3
Level 2a
Level 3
Level 2b
Level 3
11,605
1,573
16,030
37
7,930
41
19,605
1,613
10,098
All Causes
80,559
14,548
16,445
10,835
76,766
14,958
14,098
16,835
10,493
62,071
2,278
5,805
610
59,626
2,010
2,153
2,058
494
20,210
1,098
451
125
185
127
0
10,392
1,468
949
0
14
50
454
889
230
111
43
83
82
1
6
1
91
63
26
23
14
18,444
18,170
234
40
11,745
8,656
2,249
2,530
463
19
88
2
67
20
0
179
9
9
0
0
45
1
1
2
2
0
0
261
236
11
14
517
393
177
101
1,935
47
469
34
240
189
32
607
115
100
0
0
13
2
171
2
1
2
18
4
14
0
3
0
58
229
168
17
44
655
621
10
24
1,096
1,652
644
531
207
8
34
1
28
5
56
26
1
1
0
0
14
2
8
0
0
0
73
63
4
7
80
139
30
58
26,806
501
561
146
205
191
2,057
10,922
1,364
968
1
20
196
178
1,750
96
43
4,981
889
384
203
49
242
11
7
1
311
241
25
45
15,151
14,876
198
78
6,497
7,580
2,196
2,671
824
2
146
9
90
47
261
124
4
4
0
0
0
64
0
0
8
8
2
16
3
9
3
205
181
3
21
209
529
307
177
754
29
145
12
88
44
82
115
7
6
0
0
0
0
30
2
4
0
81
78
4
2
15
3
8
3
264
241
4
20
374
560
248
166
657
127
148
3
113
30
29
196
10
6
0
4
0
63
2
0
1
0
0
0
203
173
14
16
347
688
247
301
148
2
34
1
28
5
3
26
4
3
1
0
10
0
2
0
0
0
1
78
64
4
10
29
184
52
48
3,877
3,016
2,022
67
3
582
115
644
169
280
177
476
467
158
32
2
272
51
110
1
108
2,712
3,591
2,946
55
148
379
45
242
26
214
146
201
83
1
0
113
140
164
29
14
1
119
84
54
2
50
15,071
1,460
57
122
118
59
30
13
53
21
281
61
19
86
12
115
223
125
184
304
3,589
1,492
225
270
171
3
55
19
23
154
73
67
153
60
235
1,258
41
234
468
383
132
3,824
286
302
1,181
795
185
824
137
303
11,346
1,445
22
11
61
128
26
39
139
29
371
189
48
79
20
62
68
80
167
253
3,464
1,399
209
253
146
89
206
54
41
62
82
138
145
68
163
813
48
91
251
300
123
3,212
13
137
961
1,087
61
322
138
118
9,182
663
24
4
34
43
8
13
19
4
152
80
5
28
7
61
43
31
292
272
2,649
912
284
294
146
6
77
9
23
38
82
142
174
44
93
1,653
199
680
239
375
160
1,534
29
117
311
571
96
489
99
165
9,741
1,450
14
6
72
205
44
65
83
23
362
43
73
74
20
92
56
40
335
171
3,403
1,240
154
139
45
150
712
62
37
56
77
73
109
94
280
951
46
14
298
431
162
1,241
32
65
357
423
49
785
327
142
13,409
1,175
57
8
119
31
44
2
38
34
206
233
21
62
18
119
30
82
387
661
2,827
756
241
249
286
20
63
9
21
31
66
145
149
34
94
1,201
142
483
185
275
116
2,825
83
169
482
1,014
240
1,218
182
347
12,434
1,366
8
9
19
60
31
103
35
5
523
145
66
25
33
62
61
59
873
896
3,727
1,460
219
264
258
129
205
10
22
60
60
124
137
81
234
953
81
199
277
256
140
2,233
118
549
384
518
66
713
59
323
11,238
1,380
11
23
50
127
33
69
108
16
328
117
98
65
12
59
64
66
551
198
3,829
1,418
215
257
136
208
313
17
27
159
57
123
137
82
216
1,088
97
239
291
291
171
1,418
6
65
421
466
59
838
126
231
14,226
2,045
20
16
162
102
38
33
132
29
621
184
98
117
33
112
95
10
973
254
3,201
1,477
227
272
76
36
237
26
27
17
86
138
150
50
149
1,205
86
144
259
541
174
4,277
101
141
2,266
1,479
63
506
321
150
9,433
1,573
21
25
39
191
22
63
198
50
422
43
48
79
18
84
55
22
220
251
3,007
1,040
139
123
36
258
553
71
30
81
77
49
110
90
165
685
28
12
101
386
159
1,115
15
36
482
339
35
1,242
891
253

1. Tuberculosis
a. Syphilis
b. Chlamydia
c. Gonorrhoea
3. HIV/AIDS
a. Pertussis
b. Poliomyelitis
c. Diphtheria
d. Measles
e. Tetanus
6. Meningitis
7. Hepatitis B (g)
Hepatitis C (g)
8. Malaria
a. Trypanosomiasis
b. Chagas disease
c. Schistosomiasis
d. Leishmaniasis
f. Onchocerciasis
10. Leprosy
11. Dengue
13. Trachoma
a. Ascariasis
b. Trichuriasis
c. Hookworm disease
3. Otitis media

3. Stomach cancer
5. Liver cancer
6. Pancreas cancer
9. Breast cancer
12. Ovary cancer
13. Prostate cancer
14. Bladder cancer
16. Leukaemia
B. Other neoplasms
2. Bipolar disorder
3. Schizophrenia
4. Epilepsy
12. Panic disorder
14. Migraine
1. Glaucoma
2. Cataracts
2. Asthma
03/23/2016 +
W115
W116
W117
W118
W120
W121
W122
W124
W125
W126
W127
W131
W143
W144
W145
W146
W148
W149
W150
W151
W152
W153
W154
W155
W156
W157
W158
W159
I.
J.
K.
L.
M.
N.
Digestive diseases
3. Appendicitis
Skin diseases
2. Osteoarthritis
Oral conditions
1. Dental caries
3. Edentulism
III.Injuries
2. Poisonings
3. Falls
4. Fires
5. Drownings
2. Violence
3. War
928
25
360
6
497
388
59
350
83
152
1,545
124
82
6
33
247
3
3
182
151
24
772
215
442
252
111
72
5
34
452
48
29
4
154
119
111
438
62
283
357
87
53
6
23
420
16
114
3
81
54
27
619
144
326
138
80
46
4
29
1,091
97
56
9
383
294
121
360
50
209
986
91
61
6
17
315
29
65
1
126
106
77
621
184
248
240
236
148
5
82
342
5
38
2
144
114
90
629
189
293
415
248
141
6
100
445
47
203
2
192
78
49
595
129
338
276
198
136
4
55
374
10
44
3
91
43
13
599
119
341
158
82
50
4
27
3,417
2,921
924
663
1,458
1,082
484
398
3,730
2,977
514
372
707
517
550
502
566
428
857
91
374
389
219
991
496
376
54
56
140
54
102
21
50
296
260
179
67
2
381
73
68
106
54
399
376
79
218
79
164
25
81
5
3
119
86
73
13
0
1,111
146
173
358
229
959
753
165
485
104
79
19
51
25
15
183
142
7
131
4
169
11
54
21
19
243
190
91
95
4
115
29
74
27
6
250
47
23
24
0
123
45
107
10
10
133
138
110
28
-
03/23/2016 +

W000
W001
W002
W003
W004
W005
W006
W007
W009
W010
W011
W012
W013
W014
W015
W016
W017
W018
W019
W020
W021
W022
W023
W024
W025
W026
W027
W028
W029
W030
W031
W032
W033
W034
W035
W038
W039
W040
W041
W042
W049
W050
W051
W052
W053
W054
W055
W056
W057
W059
W060
W061
W062
W063
W064
W065
W066
W067
W068
W069
W070
W071
W072
W073
W074
W075
W076
W078
W079
W080
W081
W082
W083
W084
W085
W086
W087
W088
W089
W090
W091
W092
W093
W094
W095
W098
W099
W100
W101
W102
W103
W104
W105
W106
W107
W108
W109
W111
W112
W113
W115
Level 4b
Level 2b
Level 3b
Level 3b
Level 4b
Level 3b
Level 1b
Level 2b
Level 1b
Level 4
Level 2b
Level 4
Level 4
Level 4
Level 2b
Level 2a
Level 2a
Level 2b
11,605
1,573
16,030
37
7,930
41
19,605
1,613
10,098
All Causes
2,236.8
684.5
784.5
316.3
2,366.2
671.6
482.8
960.5
327.8
1,077.3
47.4
199.6
19.3
1,293.9
83.1
70.8
62.0
18.2
438.5
75.1
4.5
1.7
1.3
0.5
0.0
190.8
22.5
12.3
0.0
0.2
0.8
9.2
16.7
10.7
5.2
0.4
1.8
1.7
0.1
0.0
0.0
0.1
0.1
282.6
279.1
3.4
0.1
215.8
103.5
24.3
27.0
12.6
1.4
0.0
0.0
5.1
0.0
0.0
0.0
1.8
0.0
0.0
0.2
0.1
0.1
19.4
18.3
1.2
3.0
10.9
5.1
2.2
67.5
1.4
2.4
0.7
0.0
0.0
0.7
38.8
2.0
1.5
0.0
0.0
0.4
0.1
5.8
0.2
0.1
0.0
0.5
0.1
0.4
0.0
0.1
0.0
0.0
0.0
79.1
78.4
0.7
0.1
6.8
39.1
16.6
9.9
6.0
0.3
0.0
0.0
1.4
0.4
0.0
0.0
0.6
0.1
0.5
0.0
0.0
6.7
6.7
0.0
0.1
5.8
0.9
2.3
624.7
21.9
6.2
2.6
0.1
0.1
78.5
236.6
19.0
13.1
0.1
0.3
2.8
2.7
43.3
3.6
1.6
70.2
23.3
12.7
9.2
1.4
0.0
0.3
0.0
0.1
0.1
367.1
359.3
6.1
1.7
159.0
91.7
28.2
26.7
43.9
8.5
2.0
4.1
21.4
21.4
10.3
8.1
1.5
26.1
1.2
0.2
0.1
2.4
0.7
0.1
0.1
0.0
0.0
0.9
0.1
0.3
0.8
0.8
0.0
0.0
0.0
25.7
25.6
0.0
1.9
13.4
7.3
2.0
18.9
4.6
0.3
0.1
0.0
0.9
7.8
0.3
0.1
0.0
0.2
0.0
3.1
0.1
0.0
0.0
12.2
11.6
0.6
1.6
28.2
13.2
7.8
4.6
0.1
0.0
0.0
0.1
0.1
0.1
0.1
0.3
0.0
0.1
8.6
8.6
0.0
0.0
0.1
4.2
0.6
0.5
52.2
37.0
25.2
0.6
0.1
6.2
3.7
1.3
0.8
0.5
12.5
7.1
1.8
0.0
0.0
4.8
2.6
0.7
0.1
0.4
36.8
51.4
42.5
0.1
2.0
3.3
0.7
7.5
0.9
6.7
4.1
3.7
2.6
0.0
1.0
7.2
1.1
1.1
3.1
0.7
0.2
0.3
1,095.7
134.5
7.3
16.5
16.2
6.3
3.4
2.0
6.1
1.7
29.6
5.7
2.0
7.8
2.3
6.0
7.4
14.2
30.9
25.5
29.2
0.1
0.1
2.5
0.0
2.1
0.4
0.5
8.7
1.4
1.4
611.7
11.3
73.8
282.9
109.8
20.6
62.1
33.1
6.7
112.8
609.8
110.3
2.0
0.9
6.2
12.3
2.7
4.2
11.5
2.2
28.7
9.5
3.2
5.7
2.3
3.9
3.6
6.7
8.2
3.5
23.7
0.1
0.2
0.8
3.6
0.1
3.1
1.4
2.7
0.3
1.0
0.3
0.8
408.1
0.9
25.6
123.3
160.7
5.7
17.7
8.2
5.7
11.8
537.4
84.1
3.0
0.8
5.1
6.5
1.4
2.7
3.4
0.8
17.5
10.7
1.2
3.7
1.8
6.0
2.8
2.6
40.0
11.8
16.8
0.1
0.0
0.3
3.9
0.3
6.5
0.9
0.1
0.1
0.1
0.1
273.4
1.4
22.6
65.1
105.0
9.8
45.7
16.6
9.3
32.5
281.9
84.2
0.8
0.4
5.2
12.6
3.3
4.7
5.0
1.4
18.4
1.8
3.0
4.2
1.4
6.1
3.5
3.0
8.3
3.5
28.5
0.1
0.0
0.1
0.4
0.1
22.3
1.7
0.4
0.0
0.0
102.8
2.3
5.7
30.5
30.8
3.5
19.4
5.9
1.2
16.3
981.5
165.2
14.4
2.0
21.7
5.7
9.0
0.5
4.6
5.3
34.5
31.9
3.5
6.4
1.7
9.6
1.6
5.8
74.2
22.7
32.0
0.2
0.0
0.8
9.5
0.7
8.9
1.3
0.2
0.1
0.2
0.2
469.8
3.7
35.2
111.0
184.4
18.5
89.1
29.5
17.8
68.2
575.2
126.4
1.6
2.9
4.1
6.5
6.0
12.0
4.9
2.0
37.7
13.3
7.1
2.3
1.8
7.5
1.8
5.7
91.1
22.4
8.8
6.2
1.0
264.7
2.4
84.1
59.6
70.5
4.0
14.8
2.2
1.5
20.5
391.1
109.8
1.0
2.5
4.7
12.2
3.1
7.1
9.3
1.3
25.8
7.3
5.4
4.8
1.3
4.7
3.9
5.4
17.6
5.3
11.9
0.1
0.0
0.0
0.5
0.3
5.8
1.0
0.4
0.4
0.0
0.0
152.7
0.4
8.2
44.4
42.0
4.9
43.2
4.8
1.7
18.3
879.5
137.8
1.5
1.4
12.9
7.7
3.6
3.1
10.2
2.0
38.6
9.5
5.3
7.8
3.3
7.2
5.6
0.7
74.7
3.3
6.4
0.0
0.0
0.2
1.3
0.4
1.3
0.6
0.3
0.2
0.0
573.4
6.7
17.2
335.3
182.8
4.4
33.0
25.5
4.9
28.3
292.1
102.4
1.5
2.3
3.1
13.1
1.8
5.6
15.9
3.5
20.3
2.0
1.9
5.2
1.6
6.8
4.0
2.1
8.0
4.4
20.2
0.1
0.0
0.1
1.1
0.3
11.7
1.7
0.5
0.4
0.0
0.0
0.0
110.9
1.0
3.7
52.6
31.5
2.2
18.3
11.6
1.2
11.1

1. Tuberculosis
a. Syphilis
b. Chlamydia
c. Gonorrhoea
3. HIV/AIDS
a. Pertussis
b. Poliomyelitis
c. Diphtheria
d. Measles
e. Tetanus
6. Meningitis
7. Hepatitis B (g)
Hepatitis C (g)
8. Malaria
a. Trypanosomiasis
b. Chagas disease
c. Schistosomiasis
d. Leishmaniasis
f. Onchocerciasis
10. Leprosy
11. Dengue
13. Trachoma
a. Ascariasis
b. Trichuriasis
c. Hookworm disease
3. Otitis media

3. Stomach cancer
5. Liver cancer
6. Pancreas cancer
9. Breast cancer
12. Ovary cancer
13. Prostate cancer
14. Bladder cancer
16. Leukaemia
B. Other neoplasms
2. Bipolar disorder
3. Schizophrenia
4. Epilepsy
12. Panic disorder
14. Migraine
1. Glaucoma
2. Cataracts
2. Asthma
I. Digestive diseases
03/23/2016 +
W116
W117
W118
W120
W121
W122
W124
W125
W126
W127
W131
W143
W144
W145
W146
W148
W149
W150
W151
W152
W153
W154
W155
W156
W157
W158
W159
J.
K.
L.
M.
N.

3. Appendicitis
Skin diseases
2. Osteoarthritis
Oral conditions
1. Dental caries
3. Edentulism
III.Injuries
2. Poisonings
3. Falls
4. Fires
5. Drownings
2. Violence
3. War
3.2
46.4
0.2
54.5
49.9
1.3
1.9
0.5
0.1
15.6
0.1
-
0.4
0.0
10.3
9.5
0.3
2.4
0.9
0.0
5.9
-
4.5
2.8
0.1
15.9
13.9
4.0
5.0
0.6
0.6
5.3
0.2
0.0
0.0
-
0.5
5.3
0.1
6.6
5.3
0.9
3.9
0.4
0.1
4.5
0.1
-
8.5
6.0
0.4
30.6
27.0
7.0
7.7
1.0
0.8
8.3
0.5
0.0
0.1
-
1.5
4.3
12.7
11.8
3.3
2.6
2.2
-
0.5
2.4
0.1
14.4
11.7
2.8
2.2
0.6
0.1
7.5
0.0
-
3.5
16.8
0.1
12.1
6.0
0.2
3.0
1.5
0.0
6.7
-
0.8
1.9
0.0
7.2
5.1
0.8
3.5
0.7
0.2
3.2
0.1
0.0
-
63.8
50.3
27.3
18.8
47.5
35.2
15.1
11.8
90.9
67.7
13.4
10.8
20.8
15.4
19.0
16.6
17.5
12.5
20.3
2.6
3.2
6.7
4.6
12.9
13.5
8.6
5.0
2.6
1.2
0.4
1.8
7.9
8.5
6.1
13.4
5.2
3.9
4.5
1.8
6.4
12.3
4.6
5.9
0.9
1.4
0.2
0.2
3.3
3.3
2.9
28.5
8.6
4.3
8.2
6.2
12.0
23.2
8.1
1.4
1.5
1.3
1.9
4.8
2.6
-
4.1
0.4
0.3
0.7
0.6
9.2
5.5
3.7
4.5
1.9
1.2
1.3
0.3
7.5
2.4
1.5
3.8
1.9
1.5
0.2
0.4
4.6
5.0
4.2
0.9
3.7
2.0
-
5.9
1.8
0.4
-
13.7
1.4
2.6
-
1.8
-
0.9
-
0.8
-
03/23/2016 +

W000
W001
W002
W003
W004
W005
W006
W007
W009
W010
W011
W012
W013
W014
W015
W016
W017
W018
W019
W020
W021
W022
W023
W024
W025
W026
W027
W028
W029
W030
W031
W032
W033
W034
W035
W038
W039
W040
W041
W042
W049
W050
W051
W052
W053
W054
W055
W056
W057
W059
W060
W061
W062
W063
W064
W065
W066
W067
W068
W069
W070
W071
W072
W073
W074
W075
W076
W078
W079
W080
W081
W082
W083
W084
W085
W086
W087
W088
W089
W090
W091
W092
W093
W094
W095
W098
W099
W100
W101
W102
W103
W104
W105
W106
W107
W108
W109
W111
W112
W113
Level 4b
Level 2b
Level 3b
Level 3b
Level 4b
Level 3b
Level 1b
Level 2b
Level 1b
Level 4
Level 4
Level 2b
Level 3
Level 4
Level 4
Level 4
Level 4
Level 4
Level 4
Level 2b
Level 3
Level 2a
Level 3
Level 2a
Level 3
Level 2b
Level 3
11,605
1,573
16,030
37
7,930
41
19,605
1,613
10,098
All Causes
64,087
14,601
17,874
9,048
62,804
15,160
13,597
16,029
9,214
40,806
2,364
5,581
718
40,834
1,962
2,153
3,001
564
12,534
1,492
384
64
188
110
0
5,136
742
444
0
7
29
262
541
260
125
30
57
56
1
5
0
175
41
15
13
13
9,896
9,755
118
23
12,637
4,045
1,051
1,182
481
19
85
2
64
19
0
196
10
10
0
0
48
2
1
3
2
0
0
266
242
10
13
500
438
197
112
1,890
45
398
31
194
164
29
633
108
93
0
0
12
2
165
3
1
2
16
3
12
0
3
0
81
199
143
15
41
764
732
11
21
926
1,540
601
495
210
7
39
1
33
5
57
31
2
2
0
0
20
2
5
0
0
0
54
37
4
13
88
257
55
107
18,671
534
487
89
197
167
2,237
6,609
663
467
2
10
97
87
1,313
98
44
2,622
894
363
219
41
259
13
9
1
202
146
15
41
9,351
9,124
161
66
7,020
3,633
1,053
1,280
818
2
144
9
90
46
266
123
4
4
0
0
0
65
0
0
8
8
2
15
3
8
3
200
177
3
20
206
499
289
167
748
29
149
12
90
46
88
117
7
6
0
0
0
0
30
1
4
0
82
78
4
2
15
3
8
3
231
207
4
20
386
587
260
174
867
127
149
4
109
31
31
326
18
10
0
7
0
113
2
0
2
0
0
0
310
272
17
20
338
1,290
464
564
153
1
40
1
33
5
3
30
5
4
0
0
12
0
2
0
0
0
1
60
42
5
13
33
267
75
70
1,812
1,694
1,042
35
2
447
129
679
189
296
177
444
460
151
29
2
273
95
109
0
108
1,300
2,159
1,615
28
72
366
43
239
24
213
153
202
83
2
0
114
262
196
55
23
1
117
122
52
1
49
20,467
2,197
104
224
210
102
50
25
92
30
506
100
31
133
25
127
197
201
371
388
3,855
1,807
212
270
146
3
129
42
26
214
85
80
144
82
162
2,357
84
468
814
716
276
6,261
290
696
2,663
1,147
268
990
325
287
11,320
1,472
23
11
61
129
26
39
143
29
384
191
49
80
20
61
68
82
169
260
3,435
1,402
200
246
148
88
198
53
40
61
81
135
139
69
156
817
48
91
249
307
122
3,127
12
131
944
1,056
61
324
141
115
10,892
891
33
6
48
59
12
19
28
6
212
115
8
39
12
72
45
35
418
334
2,503
911
226
245
137
7
121
14
21
34
76
126
138
49
77
2,177
264
920
327
442
223
2,165
29
177
480
824
117
570
142
170
7,837
1,014
9
4
46
131
27
41
60
17
267
35
51
53
11
61
45
30
222
167
3,167
1,249
182
180
46
162
298
33
37
61
80
78
131
85
360
756
35
11
264
324
123
643
18
25
174
234
29
691
259
193
18,679
2,080
122
18
243
59
83
5
66
65
410
426
41
99
31
154
38
99
771
877
2,826
913
227
254
269
28
139
21
23
33
76
126
138
49
77
2,180
264
920
327
442
226
5,022
89
353
1,040
1,933
310
1,512
334
377
12,684
1,451
8
7
19
66
32
114
38
4
549
161
69
28
38
63
61
63
924
902
3,710
1,482
217
262
255
133
195
10
22
59
60
126
137
84
225
1,011
85
215
284
277
150
2,276
118
571
391
529
69
703
61
309
10,729
1,309
10
20
46
112
30
60
102
15
316
120
99
63
10
55
62
62
513
191
3,852
1,482
217
262
139
218
216
15
28
165
60
126
137
84
225
1,012
85
215
284
277
150
1,187
6
51
349
414
51
786
123
231
12,459
1,791
16
12
137
87
30
25
111
25
552
167
83
101
25
102
91
9
767
245
3,154
1,427
220
264
80
35
185
25
27
20
83
137
143
46
161
1,052
69
116
247
481
139
3,161
89
103
1,645
1,095
52
445
258
156
8,058
1,217
16
17
29
139
17
45
145
39
337
37
37
62
12
62
47
16
171
242
2,853
1,058
166
149
38
227
301
48
30
90
80
55
131
85
208
539
21
9
84
305
120
714
12
18
290
219
30
1,130
750
303

1. Tuberculosis
a. Syphilis
b. Chlamydia
c. Gonorrhoea
3. HIV/AIDS
a. Pertussis
b. Poliomyelitis
c. Diphtheria
d. Measles
e. Tetanus
6. Meningitis
7. Hepatitis B (g)
Hepatitis C (g)
8. Malaria
a. Trypanosomiasis
b. Chagas disease
c. Schistosomiasis
d. Leishmaniasis
f. Onchocerciasis
10. Leprosy
11. Dengue
13. Trachoma
a. Ascariasis
b. Trichuriasis
c. Hookworm disease
3. Otitis media

3. Stomach cancer
5. Liver cancer
6. Pancreas cancer
9. Breast cancer
12. Ovary cancer
13. Prostate cancer
14. Bladder cancer
16. Leukaemia
B. Other neoplasms
2. Bipolar disorder
3. Schizophrenia
4. Epilepsy
12. Panic disorder
14. Migraine
1. Glaucoma
2. Cataracts
2. Asthma
03/23/2016 +
W115
W116
W117
W118
W120
W121
W122
W124
W125
W126
W127
W131
W143
W144
W145
W146
W148
W149
W150
W151
W152
W153
W154
W155
W156
W157
W158
W159
I.
J.
K.
L.
M.
N.
Digestive diseases
3. Appendicitis
Skin diseases
2. Osteoarthritis
Oral conditions
1. Dental caries
3. Edentulism
III.Injuries
2. Poisonings
3. Falls
4. Fires
5. Drownings
2. Violence
3. War
1,556
42
649
5
760
618
60
522
111
267
772
179
88
9
79
252
3
3
182
151
24
786
214
455
279
113
72
5
35
526
59
40
4
183
145
135
523
74
346
333
99
51
6
38
318
13
84
3
45
28
14
449
119
217
237
84
58
4
22
1,473
151
102
10
499
384
181
556
77
348
497
106
51
8
38
330
32
71
1
129
110
77
643
186
267
226
239
142
6
90
329
5
37
2
126
100
84
605
193
267
435
239
142
6
90
393
38
161
2
169
68
49
544
121
304
484
195
138
4
50
317
8
37
3
65
27
8
484
103
261
218
84
58
4
22
2,814
2,341
916
661
1,401
1,043
493
408
3,291
2,506
514
374
716
520
570
525
591
449
693
80
279
314
154
821
473
351
47
66
140
54
102
21
49
296
255
175
66
2
369
77
72
102
51
373
358
77
198
83
177
26
73
7
3
123
84
70
14
0
946
167
154
243
177
819
786
185
478
122
78
21
50
28
17
180
140
7
129
4
173
12
52
22
19
242
195
93
99
4
113
29
81
31
8
263
45
21
24
0
135
45
107
12
12
138
142
110
32
-
03/23/2016 +

World Health Organization Organisation Mondiale de La Santé February 2009

Diunggah oleh

Informasi Dokumen

Deskripsi Asli:

Judul Asli

Hak Cipta

Format Tersedia

Bagikan dokumen Ini

Bagikan atau Tanam Dokumen

Opsi Berbagi

Apakah menurut Anda dokumen ini bermanfaat?

Apakah konten ini tidak pantas?

Hak Cipta:

Format Tersedia

World Health Organization Organisation Mondiale de La Santé February 2009

Diunggah oleh

Hak Cipta:

Format Tersedia

World Health Organization

Organisation Mondiale de la Sant

Measurement and Health Information

DISABILITY ADJUSTED LIFE YEARS